Quick Takeaways
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC filed SCHEDULE 13G for AMICUS THERAPEUTICS, INC. Common Stock (FOLD).
- Disclosed ownership: 5.2%.
- Date of event: 30 Sep 2025.
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC - 30 Sep 2025 SCHEDULE 13G Report for AMICUS THERAPEUTICS, INC. Common Stock (FOLD)
- Filing Manager
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
- Reporting Manager
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
- Symbol
- FOLD
- Shares outstanding
- 307,197,192 shares
- Disclosed Ownership
- 15,974,254 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 12 Nov 2025, 18:08:03 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 09 May 2025
- Next filing
- 09 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC disclosed 5.2% ownership in AMICUS THERAPEUTICS, INC. Common Stock (FOLD) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 09 May 2025.
- Current filing was accepted on 12 Nov 2025, 18:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 5.2% | 15,974,254 | 14,343,352 | 0 | Walter R. Randall, Jr. | Chief Compliance Officer |